Osmigen 80 mg (Osimertinib), general Tagrisso is a traditional drug used to treat advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
Osmigen is manufactured by General Medicinals Ltd. in Bangladesh.
Have to take it orally formerly diurnal with or without food.
The most common adverse responses (≥ 25) are
Diarrhea, rash, dry skin, nail toxin, stomatitis, and reduced appetite.
The below information comes from the Internet. Please consult with a croaker for medical advice.
PI & Suggestions
* Any advice on the use of the medicine is for reference only. Please consult with a croaker for medical advice. All Names, ensigns, and trademarks are the property of their separate possessors. Watermarks and QR canons are used for identification purposes only.